Roseman University of Health Sciences
Message from Dr. Ronald R. Fiscus, Assoc. Dean for Research & Professor of BioMedical Sciences in Roseman's new College of Medicine and Professor of Pharmaceutical Sciences in the College of Pharmacy
Welcome to Research at Roseman University of Health Sciences. The University has assembled outstanding teams of world-class researchers focusing on health issues that have a tremendous impact on populations in the U.S. and beyond, including cutting-edge medical research of Type-1 and Type-2 Diabetes, Obesity, many forms of Cancer (Brain Cancer, Breast Cancer, Colon Cancer, Leukemia & Lymphoma, Lung Cancer, Melanoma, Mesothelioma, Ovarian Cancer, Pancreatic Cancer and Prostate Cancer), Alzheimer’s and Parkinson's Disease, Cardiovascular Diseases, Stem Cells in Regenerative Medicine, Dental Medicine Research, Nursing Research and special 15-year experience with cutting-edge research in Pharmaceutical Practice & Pharmaceutical Sciences, with established expertise in the research of the molecular mechanisms & development of new therapies for Sustance Abuse & Mental Depression. This world-class research is being conducted at all three of Roseman's campuses, the original campus in Henderson, Nevada, our second campus in South Jordan, Utah, and our newly-developed third campus in the Summerlin (far-western) district of Las Vegas, Nevada, home of Roseman's new College of Medicine.
Our medical school researchers at the Summerlin Campus have set up the most advanced medical research instrumentation currently available within this region of the U.S. [e.g. CARS / 4-Laser (2-Photon-plus-2-Photon) Microscopy for combining 3-D micro-imaging with micro-chemical analysis, NanoPro 100 & NanoPro 1000 ("Advanced Nano-Proteomics" based on exquisitely-sensitive Capillary Electrophoresis, a specialty of Dr. Fiscus' and Dr. Le's labs), TIRF (Total Internal Reflection Fluorescence) microscopy couple with ultrasensitive Confocal Microscopy, and Roseman's newly Patented ultrasensitive Near-Infra-Red Fluorescence (NIRF)-based technology for accurately quantifying the catalytic / kinase activity of any protein kinase (of the 518 in the human genome), a technology developed in Dr. Fiscus' lab at Roseman University. This new NIRF-based technology eliminates the need for using dangerous radioisotopes, used by most other scientists in this field of research. Roseman's state-of-the-art technologies are being used to identify new biomarkers for diagnosing diseases and for developing new, more effective therapeutic agents for treating many different types of diseases (with special emphasis on Alzheimer's disease, cancers and diabetes).
We have built collaborations with renowned researchers from around the globe (including recipients of the Nobel Prize in Physiology & Medicine) to make important discoveries that will lead to novel diagnostic tools (e.g. new biomarkers for early diagnosis of Alzheimer's & Parkinson's disease, various cancers and Type-1 & Type-2 diabetes) and discovering new ways of preventing and treating these diseases.
We invite you to learn more about our world-class research teams, their state-of-the-art medical research instrumentation, and their groundbreaking research programs. Click on the specific Research Center / Program at Roseman University, listed on the left.
Ronald R. Fiscus, Ph.D.
Assoc. Dean for Research & Professor of BioMedical Sciences (Molecular Pathology & Molecular Pharmacology), College of Medicine, Professor of Pharmaceutical Sciences, College of Pharmacy, Director of the Diabetes Research Program and the Alzheimer's & Parkinson's Diseases Research Program in the College of Medicine, Senior Scientist (Molecular Pharmacologist) in our Cancer Research Center, at our Summerlin/Las Vegas Campus.
Previously, Dr. Fiscus was a Postdoctoral Fellow at UCSD Medical School and then a Senior Postdoctoral Fellow and Scientist at Stanford University Medical School. At Stanford Medical School, Dr. Fiscus worked in the lab of Dr. F. Murad, Nobel Laureate. Dr. Fiscus' research at Stanford Medical School contributed to the 1998 Nobel Prize in Physiology & Medicine on "Nitric Oxide ( NO ) Cell-Signaling Mechanism [ NO / cyclic GMP / protein kinase G ( PKG ) ] & the Pharmacology/Physiology of NO in Regulating the Cardiovascular System, Protecting Against Hypertension & Other Cardiovascular Diseases".